EU Blesses Merck's $41B Schering-Plough Deal
The European Commission said Friday that the proposed deal would not “significantly impede effective competition” in Europe.
The New Jersey-based companies already have a working relationship based on a joint venture they entered into a few years ago for marketing and studying the cholesterol drugs Vytorin and Zetia. The union of Merck and Schering would form one...
To view the full article, register now.